节点文献
雷米芬太尼呼吸抑制的半数有效血浆浓度的临床研究
Half-effective target plasma concentration of respiratory depression of remifentanil
【摘要】 目的测定靶控输注雷米芬太尼引起呼吸抑制的半数有效血浆浓度(Cp50)。方法20例择期手术病人行椎管内阻滞。按序贯法给予雷米芬太尼靶控输注20min,相邻血浆靶浓度之间比率为1·5。测定RR、SpO2、PETCO2及动脉血气。结果雷米芬太尼引起呼吸抑制的Cp50为1·8μg/L,95%可信区间为1·5~2·1μg/L。结论雷米芬太尼引起呼吸抑制的Cp50为1·8μg/L。
【Abstract】 Objective To determine the half-effective target plasma concentration (Cp 50 ) of remifentanil to cause respiratory depression. Methods Twenty patients undergoing elective operations were enrolled. Intrathecal block was given. TCI remifentanil was given by “up and down” method for 20min, and the ratio of two close plasma concentrations was 1.5. RR, SpO2, P ET CO2 and arterial gas analysis were measured. Results The CP 50 of remifentanil was 1.8 μg/L. The 95% confidence level was 1.5-2.1μg/L. Conclusion The half-effective target plasma concentration of remifentanil to cause respiratory depression was 1.8μg/L.
- 【文献出处】 临床麻醉学杂志 ,The Journal of Clinical Anesthesiology , 编辑部邮箱 ,2006年11期
- 【分类号】R614
- 【被引频次】31
- 【下载频次】170